$27.03
00.00%
Pre-Market: 4:00 PM EDT
15 minutes delayed
Myriad Genetics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Myriad Genetics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-06 | $0.05 | $-0.01 | 600.0 % |
Mar 2024 | 2024-05-07 | $-0.01 | $-0.10 | 90.0 % |
Dec 2023 | 2024-02-27 | $0.04 | $0.01 | 300.0 % |
Sep 2023 | 2023-11-06 | $-0.03 | $-0.08 | 62.5 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-06 | $211.50M | $204.95M | 3.20 % |
Mar 2024 | 2024-05-07 | $202.20M | $193.26M | 4.63 % |
Dec 2023 | 2024-02-27 | $196.60M | $194.78M | 0.93 % |
Sep 2023 | 2023-11-06 | $191.90M | $179.25M | 7.06 % |
Myriad Genetics (MYGN) is scheduled to report earnings on November 4, 2024. The last reported earnings were for reported on August 6, 2024 for Q2.
The Actual EPS was $0.05, which beat the estimate of $-0.01.
The Actual Revenue was $211.5M, which beat the estimate of $204.9M.
Browse earnings estimates, EPS, and revenue on all stocks.